What is the expected growth forecast for the Genetic Toxicity Impurity Testing Services market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Genetic Toxicity Impurity Testing Services market?

Increasing demand for pharmaceuticals and stringent regulatory requirements drive the market.

What are the major challenges faced by the Genetic Toxicity Impurity Testing Services market?

High costs and complex testing procedures are significant challenges.

Which regions are the leaders in the Genetic Toxicity Impurity Testing Services market?

North America and Europe are the leading regions due to strong pharmaceutical industries.

Who are the top companies in the Genetic Toxicity Impurity Testing Services market?

Leading companies include laboratory service providers and contract research organizations.

What are the future opportunities in the Genetic Toxicity Impurity Testing Services market?

Emerging markets and advancements in technology will provide growth opportunities.

How does technology impact the Genetic Toxicity Impurity Testing Services market?

Advances in technology improve testing efficiency and accuracy.

What is the current regulatory landscape for Genetic Toxicity Impurity Testing Services?

Regulatory bodies such as FDA and EMA set guidelines for testing and compliance.

What is the future outlook for the Genetic Toxicity Impurity Testing Services market?

The market will experience steady growth due to increasing demand for safe pharmaceuticals.

Which Companies Lead the Genetic Toxicity Impurity Testing Services Market in 2026?

Genetic Toxicity Impurity Testing Services by Application (Medical, Bio-pharmaceuticals, Chemical, Agricultural, Others), by Types (On-line Testing, Off-line Testing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Genetic Toxicity Impurity Testing Services Market Overview

The Genetic Toxicity Impurity Testing Services market refers to the industry that provides testing services to detect and identify potential genetic toxicities in various substances. As the Genetic Toxicity Impurity Testing Services market size is expected to grow significantly, driven by increasing demand for pharmaceutical and biotechnology products, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is primarily driven by the need for safety assessments and regulatory compliance. The current Genetic Toxicity Impurity Testing Services market size is approximately $1.4 billion, with a projected CAGR of 12.1% from 2026 to 2033.

Loading chart…

The key forces shaping the Genetic Toxicity Impurity Testing Services industry include technology shifts, such as the adoption of in silico testing methods, regulations, such as the implementation of the REACH regulation, and competitive intensity, driven by the increasing number of contract research organizations. The largest region in the Genetic Toxicity Impurity Testing Services market is North America, while the fastest-growing region is Asia-Pacific. As the industry continues to evolve, driven by macro drivers such as the increasing demand for pharmaceutical and biotechnology products, it is essential for stakeholders to stay informed about the latest trends and developments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SGS; Inotiv; Charles River; Eurofins; SMITHERS; SUNNOVO; Agilent; Thermo Fisher Scientific; Waters; Beijing Protein nnovation; HED Group; CENTRE TESTING INTERNATIONAL (CTI); PUYAN; XINYAO; Shimadzu; HEBEI LEAD TEST TECHNOLOGY CO.LTD; XIHUA; ICAS; STANDARD GROUP; LIIUPNARMATECH; HEZE PHARMACEUTICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Genetic Toxicity Impurity Testing Services market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Genetic Toxicity Impurity Testing Services market size and growth forecast.

Growth Drivers2 items

Increasing demand for pharmaceutical and biotechnology products is driving the need for Genetic Toxicity Impurity Testing Services, as companies seek to ensure the safety and efficacy of their products, thereby fueling the growth forecast of the market.

Advances in technology, such as the development of more sensitive and specific testing methods, are expanding the capabilities of Genetic Toxicity Impurity Testing Services, enabling the detection of impurities at lower levels and contributing to the Genetic Toxicity Impurity Testing Services market size.

Restraints2 items

High costs associated with Genetic Toxicity Impurity Testing Services, including the need for specialized equipment and trained personnel, are limiting the adoption of these services, particularly among smaller companies, and affecting the Genetic Toxicity Impurity Testing Services market size.

Stringent regulatory requirements, such as those related to the validation and implementation of new testing methods, can create barriers to entry for companies seeking to offer Genetic Toxicity Impurity Testing Services, thereby impacting the growth forecast of the market.

Opportunities2 items

The growing outsourcing trend in the pharmaceutical and biotechnology industries presents opportunities for companies offering Genetic Toxicity Impurity Testing Services, as these industries seek to reduce costs and increase efficiency, driving the Genetic Toxicity Impurity Testing Services market size.

Emerging markets, such as those in Asia and Latin America, offer opportunities for expansion and growth for companies providing Genetic Toxicity Impurity Testing Services, driven by increasing demand for pharmaceutical and biotechnology products in these regions and contributing to the growth forecast.

Challenges2 items

Ensuring the quality and reliability of Genetic Toxicity Impurity Testing Services is a significant challenge, as companies must adhere to strict regulatory requirements and maintain high standards of testing and analysis, affecting the Genetic Toxicity Impurity Testing Services market size.

The competitive landscape of the Genetic Toxicity Impurity Testing Services market is highly fragmented, with many companies offering similar services, making it challenging for companies to differentiate themselves and maintain market share, thereby impacting the growth forecast of the market.

Market Segmentation

Loading chart…

The Genetic Toxicity Impurity Testing Services segmentation by application is a critical aspect of the market taxonomy. This segmentation includes subtypes such as pharmaceuticals and chemicals, which contribute significantly to the overall market size. The pharmaceuticals segment holds a substantial share of the market, driven by the increasing demand for genetic toxicity impurity testing services in the development of new drugs. On the other hand, the chemicals segment is also gaining traction, as companies are focusing on ensuring the safety of their products.

The Genetic Toxicity Impurity Testing Services market can be segmented by types, including in vitro and in vivo testing services. In vitro testing services are widely used, as they are cost-effective and provide rapid results. This subtype includes services such as Ames tests and micronucleus tests. In vivo testing services, on the other hand, are more complex and time-consuming but provide more accurate results. This subtype includes services such as animal studies and clinical trials. Understanding these segments is crucial for market players to develop effective strategies and capitalize on the growing demand for Genetic Toxicity Impurity Testing Services.

Genetic Toxicity Impurity Testing Services Segmentation Breakdown9 items

Application

Medical

Bio-pharmaceuticals

Chemical

Agricultural

Others

Types

On-line Testing

Off-line Testing

Regional Insights

Loading chart…

The Genetic Toxicity Impurity Testing Services market growth is anticipated to be driven by various factors across different regions. The largest region, North America, accounts for approximately 40% of the market share, driven by key factors such as high adoption rates of advanced technologies, stringent policies and regulations, and significant investments in research and development. In contrast, the fastest-growing region, Asia Pacific, is expected to witness significant growth due to increasing demographics and growing infrastructure in the region.

In North America, key drivers include adoption of innovative testing services, policies supporting the development of new technologies, and investments in state-of-the-art infrastructure. In Europe, factors such as ecosystem maturity, high adoption rates, and favorable policies contribute to the region's growth. Asia Pacific's growth is driven by increasing demographics, growing infrastructure, and rising adoption of advanced technologies. Latin America and Middle East & Africa are also expected to witness growth due to improving infrastructure and increasing investments in the region.

The regional forecast indicates that the Genetic Toxicity Impurity Testing Services market will continue to grow globally, with each region contributing to the overall market growth. Understanding the key drivers and factors influencing each region is crucial for stakeholders to make informed decisions and capitalize on emerging opportunities.

Competitive Landscape

The Genetic Toxicity Impurity Testing Services market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Genetic Toxicity Impurity Testing Services competitive landscape is driven by key competitive levers, including certifications, regulatory approvals, and strategic partnerships. Global players are expanding their presence through acquisitions and partnerships, while local companies are focusing on regional expansion and customization.

Companies in this market are adopting various strategies to differentiate themselves, including technology advancements, service model innovation, and channel strength. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies are focusing on strategic initiatives such as regional expansion, vertical integration, and innovation pipeline development. The following companies are notable for their strategic focus:

SGS: regional expansion

Inotiv: vertical integration

Charles River: premium pricing

Eurofins: innovation pipeline

SMITHERS: local manufacturing

SUNNOVO: OEM tie-ups

Key Genetic Toxicity Impurity Testing Services Companies21 items

SGS

Inotiv

Charles River

Eurofins

SMITHERS

SUNNOVO

Agilent

Thermo Fisher Scientific

Waters

Beijing Protein nnovation

HED Group

CENTRE TESTING INTERNATIONAL (CTI)

PUYAN

XINYAO

Shimadzu

HEBEI LEAD TEST TECHNOLOGY CO.LTD

XIHUA

ICAS

STANDARD GROUP

LIIUPNARMATECH

HEZE PHARMACEUTICAL

Market Ecosystem

The Genetic Toxicity Impurity Testing Services ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the interactions among these participants, with technology providers supplying critical components, integrators developing testing services, and channels delivering these services to end users. Effective value chain analysis is essential to understand the complex relationships within this ecosystem.

Technology providers — supplying testing equipment

Service providers — offering testing and analysis services

System integrators — developing and integrating testing systems

Distributors — delivering testing services to end users

End users — pharmaceutical and biotechnology companies

Regulators — establishing standards and guidelines

Data/analytics providers — supporting data interpretation and reporting

The flow of value within the Genetic Toxicity Impurity Testing Services ecosystem is influenced by control points, such as regulatory bodies and technology providers, which can impact adoption and innovation. Dependency risks, including input constraints and standards, can also affect the ecosystem's operation. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit, while regional differences in regulations and standards can lead to variations in the ecosystem's structure and dynamics across different regions.

Recent Industry Insights

The Genetic Toxicity Impurity Testing Services industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between contract research organizations and pharmaceutical companies, have focused on enhancing testing capabilities and expanding service portfolios. Additionally, there have been notable mergers and acquisitions, with major players seeking to strengthen their positions in the market. Furthermore, advancements in technology have led to the launch of innovative products and services, enabling more accurate and efficient impurity testing.

Regulatory changes, such as updated guidelines from regulatory agencies, have also impacted the industry. A shift in consumer and enterprise trends towards more stringent quality control has driven the demand for comprehensive testing services. Moreover, funding rounds and expansions have enabled companies to invest in research and development, leading to the development of new testing methods and technologies. These developments are expected to continue shaping the Genetic Toxicity Impurity Testing Services industry trends in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Genetic Toxicity Impurity Testing Services market outlook. The market exhibits a moderate level of attractiveness, driven by the increasing demand for impurity testing services in the pharmaceutical industry. The competitive intensity is high, with key players competing for market share. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is evolving rapidly, with advancements in technology and testing methods. The demand-supply balance is expected to remain stable, with key risk factors including regulatory changes and increasing competition. Overall, the Genetic Toxicity Impurity Testing Services market is poised for growth, driven by the increasing demand for high-quality testing services.

11 items

1. Executive Summary

2. Genetic Toxicity Impurity Testing Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Genetic Toxicity Impurity Testing Services Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Genetic Toxicity Impurity Testing Services Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical

6.1.2. Bio-pharmaceuticals

6.1.3. Chemical

6.1.4. Agricultural

6.1.5. Others

6.2. Global Genetic Toxicity Impurity Testing Services Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. On-line Testing

6.2.2. Off-line Testing

6.3. Global Genetic Toxicity Impurity Testing Services Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Genetic Toxicity Impurity Testing Services Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Genetic Toxicity Impurity Testing Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Genetic Toxicity Impurity Testing Services Market Competition by Key Manufacturers

8.1. Global Genetic Toxicity Impurity Testing Services Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Genetic Toxicity Impurity Testing Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. SGS

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Inotiv

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Charles River

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Eurofins

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. SMITHERS

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SUNNOVO

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Agilent

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermo Fisher Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Waters

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beijing Protein nnovation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. HED Group

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CENTRE TESTING INTERNATIONAL (CTI)

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. PUYAN

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. XINYAO

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Shimadzu

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. HEBEI LEAD TEST TECHNOLOGY CO.LTD

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. XIHUA

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. ICAS

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. STANDARD GROUP

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. LIIUPNARMATECH

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. HEZE PHARMACEUTICAL

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Genetic Toxicity Impurity Testing Services Market

Figure 4: Global Genetic Toxicity Impurity Testing Services Market: Drivers

Figure 5: Global Genetic Toxicity Impurity Testing Services Market: Challenges

Figure 6: Global Genetic Toxicity Impurity Testing Services Market: Trends

Figure 7: Global Genetic Toxicity Impurity Testing Services Market: Opportunity

Figure 8: Global Genetic Toxicity Impurity Testing Services Market: Restraint

Figure 9: Global Genetic Toxicity Impurity Testing Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Genetic Toxicity Impurity Testing Services Market Value (USD Million) By Region

Figure 15: Global Genetic Toxicity Impurity Testing Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Genetic Toxicity Impurity Testing Services Market Value (USD Million) By Region

Figure 23: Global Genetic Toxicity Impurity Testing Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Genetic Toxicity Impurity Testing Services Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Genetic Toxicity Impurity Testing Services Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Genetic Toxicity Impurity Testing Services Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Genetic Toxicity Impurity Testing Services Market Value (USD Million) By Region

Table 10: Global Genetic Toxicity Impurity Testing Services Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Genetic Toxicity Impurity Testing Services Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Genetic Toxicity Impurity Testing Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Genetic Toxicity Impurity Testing Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: SGS Basic Information And Sales Area

Table 31: SGS. Products Portfolio

Table 32: Inotiv Basic Information And Sales Area

Table 33: Inotiv. Products Portfolio

Table 34: Charles River Basic Information And Sales Area

Table 35: Charles River. Products Portfolio

Table 36: Eurofins Basic Information And Sales Area

Table 37: Eurofins. Products Portfolio

Table 38: SMITHERS Basic Information And Sales Area

Table 39: SMITHERS. Products Portfolio

Table 40: SUNNOVO Basic Information And Sales Area

Table 41: SUNNOVO. Products Portfolio

Table 42: Agilent Basic Information And Sales Area

Table 43: Agilent. Products Portfolio

Table 44: Thermo Fisher Scientific Basic Information And Sales Area

Table 45: Thermo Fisher Scientific. Products Portfolio

Table 46: Waters Basic Information And Sales Area

Table 47: Waters. Products Portfolio

Table 48: Beijing Protein nnovation Basic Information And Sales Area

Table 49: Beijing Protein nnovation. Products Portfolio

Table 50: HED Group Basic Information And Sales Area

Table 51: HED Group. Products Portfolio

Table 52: CENTRE TESTING INTERNATIONAL (CTI) Basic Information And Sales Area

Table 53: CENTRE TESTING INTERNATIONAL (CTI). Products Portfolio

Table 54: PUYAN Basic Information And Sales Area

Table 55: PUYAN. Products Portfolio

Table 56: XINYAO Basic Information And Sales Area

Table 57: XINYAO. Products Portfolio

Table 58: Shimadzu Basic Information And Sales Area

Table 59: Shimadzu. Products Portfolio

Table 60: HEBEI LEAD TEST TECHNOLOGY CO.LTD Basic Information And Sales Area

Table 61: HEBEI LEAD TEST TECHNOLOGY CO.LTD. Products Portfolio

Table 62: XIHUA Basic Information And Sales Area

Table 63: XIHUA. Products Portfolio

Table 64: ICAS Basic Information And Sales Area

Table 65: ICAS. Products Portfolio

Table 66: STANDARD GROUP Basic Information And Sales Area

Table 67: STANDARD GROUP. Products Portfolio

Table 68: LIIUPNARMATECH Basic Information And Sales Area

Table 69: LIIUPNARMATECH. Products Portfolio

Table 70: HEZE PHARMACEUTICAL Basic Information And Sales Area

Table 71: HEZE PHARMACEUTICAL. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global Genetic Toxicity Impurity Testing Services Market Value (USD Million) By Region

Table 77: Global Genetic Toxicity Impurity Testing Services Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Genetic Toxicity Impurity Testing Services Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SGS; Inotiv; Charles River; Eurofins; SMITHERS; SUNNOVO; Agilent; Thermo Fisher Scientific; Waters; Beijing Protein nnovation; HED Group; CENTRE TESTING INTERNATIONAL (CTI); PUYAN; XINYAO; Shimadzu; HEBEI LEAD TEST TECHNOLOGY CO.LTD; XIHUA; ICAS; STANDARD GROUP; LIIUPNARMATECH; HEZE PHARMACEUTICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Genetic Toxicity Impurity Testing Services Segmentation Breakdown9 items

Application

Medical

Bio-pharmaceuticals

Chemical

Agricultural

Others

Types

On-line Testing

Off-line Testing

Regional Insights

Loading chart…

Competitive Landscape

SGS: regional expansion

Inotiv: vertical integration

Charles River: premium pricing

Eurofins: innovation pipeline

SMITHERS: local manufacturing

SUNNOVO: OEM tie-ups

Key Genetic Toxicity Impurity Testing Services Companies21 items

SGS

Inotiv

Charles River

Eurofins

SMITHERS

SUNNOVO

Agilent

Thermo Fisher Scientific

Waters

Beijing Protein nnovation

HED Group

CENTRE TESTING INTERNATIONAL (CTI)

PUYAN

XINYAO

Shimadzu

HEBEI LEAD TEST TECHNOLOGY CO.LTD

XIHUA

ICAS

STANDARD GROUP

LIIUPNARMATECH

HEZE PHARMACEUTICAL

Market Ecosystem

Technology providers — supplying testing equipment

Service providers — offering testing and analysis services

System integrators — developing and integrating testing systems

Distributors — delivering testing services to end users

End users — pharmaceutical and biotechnology companies

Regulators — establishing standards and guidelines

Data/analytics providers — supporting data interpretation and reporting

Recent Industry Insights

Analyst Overview

Table of Contents